Metoprolol (MET)

DRUG4 trials

Sponsors

Mylan Bertek Pharmaceuticals, Tel-Aviv Sourasky Medical Center, Zagazig University, Fujian Provincial Hospital

Conditions

Cardiogenic Shock Post Myocardial InfarctionGeneral Anesthesia; Tracheal IntubationHypertensionST Segment Elevation Myocardial Infarction (STEMI)Stress Response of Endotracheal Intubation and Surgical Field Clarity in FESS

Phase 3

Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension

CompletedNCT00142584

Mylan Bertek PharmaceuticalsHypertension

Start: 2005-08-31End: 2008-03-31Updated: 2022-03-15

Phase 4

Dose-Response Interaction of Metoprolol and Sufentanil for Attenuating Hemodynamic Responses in Tracheal Intubation

Not yet recruitingNCT07597564

Fujian Provincial HospitalGeneral Anesthesia; Tracheal Intubation

Start: 2026-06-22End: 2027-05-22Target: 900Updated: 2026-05-20

Unknown Phase

Early Beta Blocker Administration in STEMI Patients With SCAI B Status

RecruitingNCT06967194

Tel-Aviv Sourasky Medical CenterCardiogenic Shock Post Myocardial Infarction, ST Segment Elevation Myocardial Infarction (STEMI)

Start: 2025-05-21End: 2027-06-30Target: 200Updated: 2025-05-28

Melatonin vs Metoprolol or Dexmedetomidine to Improve Surgical Field in FESS

CompletedNCT07568873

Zagazig UniversityStress Response of Endotracheal Intubation and Surgical Field Clarity in FESS

Start: 2024-01-25End: 2025-01-15Updated: 2026-05-06